Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Linsitinib

EU orphan designation number: EU/3/12/977
Active ingredient: Linsitinib
Indication: Treatment of adrenal cortical carcinoma
Sponsor: Astellas Pharma Europe B.V.
Sylviusweg 62, 2333 BE Leiden, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
04/04/2012 Orphan designation EMA/OD/145/11 (2012)2347 of 02/04/2012
05/02/2013 Change of name and/or address of sponsor
08/02/2013 Removal of orphan designation from Community Register